Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Bruker Corporation    BRKR

BRUKER CORPORATION (BRKR)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 05:40pm CEST

NEW YORK, Nov. 10, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bruker Corporation ("Bruker" or the "Company") (NASDAQ: BRKR). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Bruker and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

On November 9, 2017, post-market, Bruker advised investors that on October 19, 2017, the Company received a notice of investigation and subpoena to produce documents from the U.S. Securities and Exchange Commission's ("SEC") Division of Enforcement. The SEC subpoena seeks information related to an employee terminated as part of a restructuring and matters involving Company policies, accounting practices related to revenue recognition and restructuring activities, as well as related financial reporting, disclosure, and compliance matters since January 2013. The subpoena also seeks information on previously identified material weakness in internal controls over accounting for income taxes, related financial reporting matters and certain payments for non-employee travel expenses. On this news, Bruker's share price has fallen during intraday trading on November 10, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

View original content:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-bruker-corporation---brkr-300553913.html

SOURCE Pomerantz LLP


© PRNewswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BRUKER CORPORATION
01:01pBRUKER : Announces Date and Time of Third Quarter 2018 Earnings Release and Webc..
PR
10/16BRUKER : Completes Acquisition of Majority Interest in Infectious Disease Molecu..
PR
10/16BRUKER : Launches the S2 POLAR™ High-Performance, Multi-Element Benchtop E..
PR
10/01BRUKER : Announces Breakthrough Proteomics and Lipidomics Workflow Advances for ..
PR
09/14BRUKER : Introduces New High Performance Preclinical PET/CT Si78 System
PR
09/07BRUKER CORPORATION : to Present at the 16th Annual Morgan Stanley Global Healthc..
PR
08/31BRUKER CORPORATION : Ex-dividend day for
FA
08/24BRUKER : Announces Agreement to Acquire Majority in Infectious Disease-focused M..
PR
08/14BRUKER : Features the Use of Nuclear Magnetic Resonance for Early disease detect..
AQ
08/13BRUKER : Announces Quarterly Dividend
PR
More news
News from SeekingAlpha
10/16Bruker completes acquisition of Hain Lifescience 
10/16Bruker launches the S2 POLAR benchtop EDXRF analyzer for the petrochemical in.. 
10/09Premarket analyst action - healthcare 
09/20HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (09/20/2018) 
09/20Premarket analyst action - healthcare